This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Tuesday, November 10, 2015
President of Malta presents €1.2 million worth of Hepatitis C medication to government
President presents €1.2 million worth of Hepatitis C medication to government
The President said that she is satisfied that after a year and a half of negotiations and talks, she has managed to get extraordinary prices for this medicine, which totally cures Hepatitis C. The President initially held talks with specialists who made her aware of the new complete cure for Hepatitis C. Further discussions were held with the pharmaceutical company supplying the drug in Malta, A M Mangion Ltd., and Gilead, the global company that developed and manufactured the cure. Following negotiations held both in Malta and abroad, the President succeeded in attaining exceptional rates to provide the cure the cure for Hepatitis C.
No comments:
Post a Comment